Please assess the completion status of the following clinical trial:

Trial Title: The Potential Effects and Mechanisms of Flax Lignans on Type 2 Diabetes Mellitus

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2/PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Diagnosed type 2 diabetes~* Age: 50-79 years old~* LDL-cholesterol more than 2.9 mmol/l~Exclusion Criteria:~* Current or previous (within 6 months) use of estrogen therapy~* Cancer~* Chronic gastrointestinal diseases~* Current use of antibiotics~* Any severe liver or renal diseases~* Systolic blood pressure more than 180 mmHg or phase 3 hypertension~* Any severe mental diseases~* Severe cardio- or cerebro-vascular diseases

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: 79 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).